Clinical Trial Update: Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating contrast-enhanced ultrasound imaging to diagnose recurrent renal cell carcinoma after ablation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: john eisenbrey | Conditions: Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma | Phase 2 | Status: RECRUITING